-- 
Novartis Unit Profiting From J&J Recalls, CFO Tells Reuters

-- B y   E v a   v o n   S c h a p e r
-- 
2011-05-12T10:56:14Z

-- http://www.bloomberg.com/news/2011-05-12/novartis-unit-profiting-from-j-j-recalls-cfo-tells-reuters.html
Novartis AG (NOVN) ’s Chief Financial Officer
Jon Symonds said the company’s consumer drug unit is profiting
from  Johnson & Johnson (JNJ) ’s product recalls, Reuters reported,
citing comments to the news agency’s health summit in New York.  The company hopes to hold on to a portion of the increased
sales, Symonds said yesterday, according to Reuters. The CFO
also said Novartis is interested in acquiring other consumer
brands, the news agency reported.  To contact the reporter on this story:
Eva Von Schaper in Munich Bureau at 
 evonschaper@bloomberg.net   To contact the editor responsible for this story:
Phil Serafino at 
 pserafino@bloomberg.net  